No name

Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

Schizohrenia research & FAQs


Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

Jeffrey Borenstein, M.D.
Jeffrey Borenstein, M.D.
March 15, 2013

For immediate release: March 15, 2013

Contact:
Sally Corbett,
scorbett@bbrfoundation.org
516-829-0091

(Metro New York City/Great Neck, NY) The Board of Directors of the Brain &...

Transcranial Magnetic Stimulation used generally to treat depression, is now being used to treat schizophrenia symptoms
Transcranial Magnetic Stimulation
March 14, 2013

A team of researchers from the University of Toronto, led by Zafiris J. Daskalakis, M.D., Ph.D., FRCP(C), three-time NARSAD Grantee and Associate Professor in the Department of Psychiatry, recently discovered that...

March 13, 2013

Contact:
Sally Corbett
516-829-0091
scorbett@bbrfoundation.org

(Great Neck, NY – March 13, 2013) The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research...

Brain & Behavior Research Foundation Scientific Council Member, Karl Deisseroth, M.D., Ph.D. of Stanford University, Expert on Optogenetics and Depression
Karl Deisseroth, M.D., Ph.D.
March 13, 2013

In 2005, Brain & Behavior Research Foundation Scientific Council Member, Karl Deisseroth, M.D., Ph.D. of Stanford University, used his NARSAD Young Investigator Grant to develop the new technology, ‘optogenetics,’...

NARSAD Distinguished Investigator Grantee, Martin Schalling, M.D., Ph.D., Karolinska Institutet in Sweden, Expert on Schizophrenia and Bipolar Disorder Research
Martin Schalling, M.D., Ph.D.
March 12, 2013

NARSAD Distinguished Investigator Grantee, Martin Schalling, M.D., Ph.D. was among a team of researchers from the Karolinska Institutet in Sweden who recently discovered a genetic variant of an enzyme in the brain that...

Pages

Subscribe to